Mercury Computer Systems, Inc. (NASDAQ: MRCY) announced that the Food and Drug Administration (FDA) has granted clearance to market Visage(TM) PACS and Visage CS (picture archiving and communications system and client server) products as medical devices in the United States.
For more than a decade, Mercury has sold computer systems and software as components to medical diagnostic imaging OEMs. In June, Mercury’s Commercial Imaging and Visualization group received ISO 13485 certification for its quality management system for medical devices.
“FDA approval of Visage PACS and Visage CS demonstrates Mercury’s commitment to provide medical-quality products, developed under the control of a medical-grade quality management system, for the benefit of our partners’ product development and regulatory approval cycle,” said Marcelo Lima, Vice President and General Manager of Commercial Imaging and Visualization at Mercury Computer Systems.
Visage PACS and Visage CS are fully scalable medical image management and distribution solutions that enable clinicians and radiologists to seamlessly utilize the 3D functionality of Visage CS while benefiting from the intuitive workflow from Visage PACS. The Visage products offer a best in class, high- performance 2D/3D diagnostic image management system. With the use of Visage PACS and Visage CS, a virtually unlimited number of medical professionals can securely view images within the hospital network and over the web on any standard PC connected to the network, whether within or outside the department or institution.
For more information on the Visage product family and Mercury’s 3D to the Core solutions, visit Mercury at RSNA 2006 November 26-30 at McCormick Place in Chicago, Illinois, in the South Building — Hall A, Booth #4383; contact Mercury at (866) 627-6951.
Mercury Computer Systems, Inc. — Where Challenges Drive Innovation
Mercury Computer Systems is the leading provider of computing systems and software for data-intensive applications that include image processing, signal processing, and visualization. With a strong commitment to innovation, our expertise in algorithm optimization, systems development, and silicon design is blended with software application knowledge and industry-standard technologies to solve unique computing challenges. We work closely with our customers to architect solutions that have a meaningful impact on everyday life: detecting aneurysms; designing safer, more fuel-efficient aircraft; identifying security threats; discovering oil; developing new drugs; and visualizing virtually every aspect of scientific investigation.
Mercury’s comprehensive, purpose-built solutions capture, process, and present data for the world’s largest medical imaging companies, 8 of the 10 top defense prime contractors, and other leading Fortune 500 and mid-market companies in semiconductor, energy, telecommunications, and other industries. Our dedication to performance excellence and collaborative innovation continues a 23-year history in enabling customers to stay at the forefront of the markets they serve.
Mercury is based in Chelmsford, Massachusetts and serves customers worldwide through a broad network of direct sales offices, subsidiaries, and distributors. We are listed on the Nasdaq National Market (NASDAQ: MRCY).
Visage is a registered trademark of Mercury Computer Systems, Inc.